Brought to you by 
Strakan in deal with Cellegy for EU marketing of Tostrex
25 Aug 2004
Executive Summary
Cellegy Pharmaceuticals (transdermal and topical drug delivery) has signed on Strakan (women's health, aging, and dermatology) as the future marketer of Tostrex testosterone gel in Europe. The candidate is under regulatory review now.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Specialty Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- Includes Contract
- Includes Royalty or Profit Split Information
- Marketing (Licensing)
- Product or Technology Swap
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Strakan in deal with Cellegy for EU marketing of Tostrex
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice